US 6635614
Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol
expired A61KA61K38/00A61K48/00
Quick answer
US patent 6635614 (Use of lecithin-cholesterol acyltransferase (LCAT) to reduce accumulation of cholesterol) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Oct 21 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K38/00, A61K48/00